Sobi names new VP, manufacturing
This article was originally published in Scrip
Executive Summary
Swedish Orphan Biovitrum (Sobi), which develops treatments for rare diseases, has named Kirsti Gjellan senior vice-president of manufacturing operations – effective September 2014. Prior to joining Sobi, Ms Gjellan was managing director and site leader at Pfizer's Strängnäs site, as well as a member of Pfizer Health's board. She succeeds Lena Nyström, who is retiring later this year.